Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer
Stopped Study placed on hold.
Conditions
- Anatomic Stage IV Breast Cancer AJCC v8
- HER2 Positive Breast Carcinoma
- Metastatic Breast Carcinoma
- Refractory Breast Carcinoma
Interventions
- DRUG: Alpha-tocopheryloxyacetic Acid
- BIOLOGICAL: Trastuzumab
Sponsor
Veana Therapeutics
Collaborators